A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

NCT05897320 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

315

Enrollment

INDUSTRY

Sponsor class

Conditions

Episodic Migraine

Interventions

DRUG: Eptinezumab
DRUG: Placebo

Sponsor

H. Lundbeck A/S